Home

PAR-20-221 - NIDA Avant-Garde Award Program for HIV/AIDS and Substance Use Disorder Research (DP1, Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

On This Page: 5

Active NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of Special Interest (NOSI): Targeting the Endocannabinoid System for Brain Health and Acute and Chronic Diseases NOT-DA-22-048 NIDA , NCI , NIDCR Jan 9, 2023 Jan 8, 2026 R01, R21, DP2, DP1, K99/R00, K01, R36, K08, R15, K24
Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings NOT-DA-21-060 NIDA , NIMH Nov 18, 2021 Jan 8, 2025 R34, R01, DP1, DP2
Notice of Special Interest (NOSI): Advancing HIV/AIDS Research through Computational Neuroscience NOT-DA-21-030 NIDA Jun 22, 2021 Jan 8, 2025 R01, R21, R03, DP2, DP1, K99/R00, K01, R36, P01, R15, K24

Expired NOSIs

Title Notice Number Organization Release
Date		 Expiration
Date		 Activity
Code(s)
Notice of NIDA Participation in NOT-MH-21-105, "Notice of Special Interest: Advancing Health Communication Research on HIV Prevention, Treatment and Cure" NOT-DA-21-079 NIDA Feb 16, 2022 n/a R21, R01, R34, DP1, DP2, R03
Notice of Special Interest (NOSI): Identification of Biomarkers of HIV Pathogenesis and Substance Use Disorder Comorbidity NOT-DA-21-014 NIDA Mar 31, 2021 Sep 8, 2024 R01, R21, DP2, DP1, K99/R00, K01, R36, P01, R15, K24


Technical Issues: E-mail OER Webmaster   




  • National Institutes of Health (NIH), 9000 Rockville Pike, Bethesda, Maryland 20892

  • NIH... Turning Discovery Into Health